| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alcohol intake and bone status in elderly Japanese men: Baseline data from the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study
|
Kouda, Katsuyasu
|
|
2011
|
49 |
2 |
p. 275-280
6 p.
|
article
|
| 2 |
Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it
|
Saxon, Leanne K.
|
|
2011
|
49 |
2 |
p. 184-193
10 p.
|
article
|
| 3 |
Announcements
|
|
|
2011
|
49 |
2 |
p. 313-
1 p.
|
article
|
| 4 |
ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans
|
John, Markus R.
|
|
2011
|
49 |
2 |
p. 233-241
9 p.
|
article
|
| 5 |
Combination of radiograph-based trabecular and geometrical parameters can discriminate cervical hip fractures from controls in individuals with BMD in non-osteoporotic range
|
Pulkkinen, P.
|
|
2011
|
49 |
2 |
p. 290-294
5 p.
|
article
|
| 6 |
Corrigendum to “Epimedium-Derived Flavonoids Promote Osteoblastogenesis and Suppress Adipogenesis in Bone Marrow Stromal Cells while Exerting an Anabolic Effect on Osteoporotic Bone” [Bone 45 (2009) 534–544]
|
Peng, Songlin
|
|
2011
|
49 |
2 |
p. 312-
1 p.
|
article
|
| 7 |
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
|
Kostenuik, Paul J.
|
|
2011
|
49 |
2 |
p. 151-161
11 p.
|
article
|
| 8 |
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
|
Ominsky, Michael S.
|
|
2011
|
49 |
2 |
p. 162-173
12 p.
|
article
|
| 9 |
Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone
|
Syed, Farhan A.
|
|
2011
|
49 |
2 |
p. 208-216
9 p.
|
article
|
| 10 |
Dose response of bone-targeted enzyme replacement for murine hypophosphatasia
|
Yadav, Manisha C.
|
|
2011
|
49 |
2 |
p. 250-256
7 p.
|
article
|
| 11 |
Editorial Board
|
|
|
2011
|
49 |
2 |
p. i-ii
nvt p.
|
article
|
| 12 |
Effect of ghrelin on bone mass density: The InChianti study
|
Napoli, Nicola
|
|
2011
|
49 |
2 |
p. 257-263
7 p.
|
article
|
| 13 |
Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women
|
Mödder, Ulrike I.
|
|
2011
|
49 |
2 |
p. 202-207
6 p.
|
article
|
| 14 |
Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women
|
Scheid, J.L.
|
|
2011
|
49 |
2 |
p. 194-201
8 p.
|
article
|
| 15 |
High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts
|
Lee, Hye-Lim
|
|
2011
|
49 |
2 |
p. 242-249
8 p.
|
article
|
| 16 |
IBMS Board of Directors
|
|
|
2011
|
49 |
2 |
p. 147-
1 p.
|
article
|
| 17 |
IBMS Corporate Partners
|
|
|
2011
|
49 |
2 |
p. 148-
1 p.
|
article
|
| 18 |
IBMS Membership Application
|
|
|
2011
|
49 |
2 |
p. 149-
1 p.
|
article
|
| 19 |
In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption
|
Dong, X. Neil
|
|
2011
|
49 |
2 |
p. 174-183
10 p.
|
article
|
| 20 |
Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts
|
Naot, Dorit
|
|
2011
|
49 |
2 |
p. 217-224
8 p.
|
article
|
| 21 |
Serial FIB/SEM imaging for quantitative 3D assessment of the osteocyte lacuno-canalicular network
|
Schneider, Philipp
|
|
2011
|
49 |
2 |
p. 304-311
8 p.
|
article
|
| 22 |
The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat
|
Campbell, Graeme M.
|
|
2011
|
49 |
2 |
p. 225-232
8 p.
|
article
|
| 23 |
The differentiation of human adipose-derived stem cells (hASCs) into osteoblasts is promoted by low amplitude, high frequency vibration treatment
|
Prè, D.
|
|
2011
|
49 |
2 |
p. 295-303
9 p.
|
article
|
| 24 |
The skeletal effects of the tyrosine kinase inhibitor nilotinib
|
O'Sullivan, Susannah
|
|
2011
|
49 |
2 |
p. 281-289
9 p.
|
article
|
| 25 |
The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells
|
Egusa, Hiroshi
|
|
2011
|
49 |
2 |
p. 264-274
11 p.
|
article
|
Journal description